The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...

Shares of Grifols GRFS lost over 7% on Wednesday after the company announced that Canada-based Brookfield Asset Management ...

RMZ Living Partners, covering RMZ Living, is projected to generate $2.5 billion in revenue by 2027. (Official Website) RMZ, ...

Among French lenders, Societe Generale and BNP Paribas fell around 2% each. The risk premium investors demand to hold French debt rose to its highest level since 2012, a sign of investor angst over ...

As of September 30, 2024, and in line with June 30, 2024, the Company continued to report its senior secured loan ($22.7 million) and its royalty financing ($9.0 million) as current liabilities as a ...

MicroStrategy’s Bitcoin acquisitions make it a standout in corporate finance. See why MSTR stock offers strong long-term ...

The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

Grifols SA needs to focus on financial restructuring and address corporate governance issues to win over investors after ...

Plus, Brookfield drops deal for Spanish healthcare group Grifols and Sequoia Capital’s spun-off China unit hunts for global deals ...

BIP currently has four series of Preferred Units outstanding and that trade on the TSX. Under BIP’s normal course issuer bid, BIP is authorized to repurchase up to 10% of the total public float of ...